Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 30

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 30
---
laws of Semnur Pharmaceuticals, Inc., as in effect as of 
 the date hereof.                                                                             |

1

| • |     | “Current Semnur Charter” means the Amended and Restated Certificate of Incorporation of Semnur 
 Pharmaceuticals, Inc., as amended, and as in effect as of the date hereof.                     |

| • |     | “Denali Board” means the board of directors of Denali. |

| • |     | “Denali Class A Ordinary Shares” means Denali’s Class A ordinary 
 shares, par value $0.0001 per share.                             |

| • |     | “Denali Class B Ordinary Shares” means Denali’s Class B ordinary 
 shares, par value $0.0001 per share.                             |

| • |     | “Denali Ordinary Shares” means the Denali Class A Ordinary Shares, par value $0.0001 per                             
 share, and the Denali Class B Ordinary Shares, par value $0.0001 per share, in each case prior to the Domestication. |

| • |     | “Denali Private Placement Shares” means the 510,000 Denali Class A Ordinary Shares 
 underlying the Denali Private Placement Units.                                     |

| • |     | “Denali Private Placement Units” means the 510,000 private placement units sold in a private 
 placement to Sponsor consummated on April 6, 2022 in connection with the IPO.                |

| • |     | “Denali Private Placement Warrants” means the 510,000 private placement warrants underlying 
 the Denali Private Placement Units.                                                         |

| • |     | “Denali Promissory Notes” means (i) the Working Capital Loans, (ii) the convertible                                                                                                                                                                
 promissory note dated July 11, 2023, by and between Denali and FutureTech Capital LLC, a Delaware Limited Liability Company (“FutureTech”) in the total principal amount of $825,000, which bears interest equivalent to the lowest                
 short-term applicable federal rate and may be converted in whole or in part into additional Denali Class A Ordinary Shares at a conversion price of $10.00 per ordinary share, (iii) the convertible promissory note dated October 11,             
 2023, by and between Denali and FutureTech in the total principal amount of $450,000, which bears no interest and may be converted in whole or in part into additional Denali Class A Ordinary